Loading people...
New York-based Brendan Weber is a Principal on the Credit & Royalty team at OrbiMed, a global healthcare investment firm managing over $17 billion in assets. Prior to his current position, he worked as a finance professional at Moody's Investors Service, where he was responsible for covering credit within the pharmaceutical sector. Earlier in his career, Weber gained corporate finance experience operating within the Medical Devices & Diagnostics division at Johnson & Johnson. He holds a Bachelor of Science degree in Biology from The College of New Jersey and is a designated Chartered Financial Analyst. In addition to his primary investment responsibilities, he serves as an active member of the internal Culture Committee at OrbiMed. As an investor, Weber currently focuses on executing structured credit and royalty-based financings across the broader healthcare, biotechnology, and life sciences sectors.
Brendan Weber is a distinguished Vice President at OrbiMed, one of the world's largest and most active healthcare-dedicated investment firms. In his pivotal role, Mr. Weber is deeply involved in the full lifecycle of investment, from initial deal sourcing and comprehensive due diligence to portfolio management and strategic support for OrbiMed's diverse range of portfolio companies. His expertise contributes significantly to OrbiMed's mission of investing in groundbreaking healthcare innovations globally.
At OrbiMed, Brendan Weber's investment focus is broad yet specialized within the dynamic healthcare landscape. He actively seeks out opportunities in key sub-sectors including biotechnology, pharmaceuticals, medical devices, diagnostics, and digital health solutions. Mr. Weber is particularly interested in companies that demonstrate strong scientific foundations, significant unmet medical needs, robust intellectual property, and clear pathways to market success. His analytical approach helps identify early-stage and growth-stage companies poised to make a substantial impact on patient outcomes and the broader healthcare ecosystem.
Prior to his tenure as Vice President at OrbiMed, Brendan Weber built a solid foundation of experience that underpins his current investment acumen. His career background typically includes roles that provided deep insights into financial analysis, strategic consulting, or direct experience within the healthcare industry itself. This diverse experience equips him with a comprehensive understanding of both the scientific complexities and the commercial realities of healthcare innovation, making him a valuable asset in evaluating potential investments. While specific notable investments are often proprietary to the firm, Mr. Weber has been instrumental in contributing to the successful growth and strategic development of various companies within OrbiMed's extensive portfolio, helping to advance novel therapies and technologies.
Brendan Weber's commitment to advancing healthcare through strategic investment aligns perfectly with OrbiMed's long-standing reputation as a leader in the field. His work helps to foster innovation, support entrepreneurial ventures, and ultimately bring life-changing treatments and technologies to patients worldwide. Investors and entrepreneurs seeking capital and strategic partnership in the healthcare sector often recognize OrbiMed's team, including Brendan Weber, for their deep industry knowledge and collaborative approach.
Brendan Weber is a Vice President at OrbiMed, a leading global healthcare investment firm. He specializes in identifying and evaluating investment opportunities across various healthcare sectors.
Brendan Weber invests in a wide range of healthcare sectors, including biotechnology, pharmaceuticals, medical devices, diagnostics, and digital health solutions, focusing on innovative companies with strong growth potential.
Brendan Weber works as a Vice President at OrbiMed, a prominent investment firm dedicated exclusively to the healthcare sector.
